CRSP

CRISPR Therapeutics AG

Jun 04 • 04:00PM ET

56.95

+4.87 9.35 %

Healthcare • Biotechnology • Switzerland • Mid • NASD

Peers: BEAM NTLA EDIT BMRN INCY VIR ALNY IONS VRTX JAN

| Held by: ARKK IWM ARKG XBI VXF IWN IBB VTWO SCHA SCHM

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-6.21	Insider Own	7.15%	Shs Outstand	96.39M	Perf Week	1.01%
Market Cap	5.49B	Forward P/E	-	EPS next Y	-3.62	Insider Trans	-3.26%	Shs Float	89.55M	Perf Month	8.72%
Enterprise Value	3.84B	PEG	-	EPS next Q	-1.20	Inst Own	72.73%	Short Float	30.48%	Perf Quarter	-0.66%
Income	-568.53M	P/S	1339.70	EPS this Y	24.66%	Inst Trans	0.79%	Short Ratio	14.34	Perf Half Y	10.41%
Sales	4.10M	P/B	3.03	EPS next Y	25.83%	ROA	-23.24%	Short Interest	27.29M	Perf YTD	8.60%
Book/sh	18.83	P/C	2.25	EPS next 5Y	29.57%	ROE	-31.21%	52W High	78.48 -27.43%	Perf Year	49.67%
Cash/sh	25.32	P/FCF	-	EPS past 3/5Y	8.21% -4.10%	ROIC	-22.01%	52W Low	37.02 53.84%	Perf 3Y	-12.38%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	43.09% 37.31%	Gross Margin	-5283.40%	Volatility	5.31% 5.05%	Perf 5Y	-49.73%
Dividend TTM	-	EV/Sales	936.15	EPS Y/Y TTM	-37.55%	Oper. Margin	-13408.29%	ATR (14)	2.87	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	17.96	Sales Y/Y TTM	-89.11%	Profit Margin	-13856.54%	RSI (14)	60.02	Recom	1.88
Dividend Gr. 3/5Y	- -	Current Ratio	17.96	EPS Q/Q	19.13%	SMA20	9.14%	Beta	1.71	Target Price	80.62
Payout	-	Debt/Eq	0.43	Sales Q/Q	68.55%	SMA50	9.42%	Rel Volume	1.73	Prev Close	52.08
Employees	-	LT Debt/Eq	0.42	Earnings	May 04 AMC	SMA200	2.38%	Avg Volume	1.90M	Price	56.95
IPO	Oct 19, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	-5.05% -75.96%	Trades		Volume	3,295,988	Change	9.35%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)